Photobiomodulation for Prevention and Treatment of Oral Mucositis: Part II (214)

9:45 am – 10:45 am Friday, September 16
Oral mucositis is a significant and common toxicity experienced by patients who receive high-dose chemotherapy as a preparatory regimen for a hematopoietic cell transplant (HCT). Photobiomodulation has been found to be feasible with significant efficacy in preventing the progression of oral mucositis in patients undergoing HCT.
This session will expand upon the session delivered last year and will describe the outcomes of our institutional protocol for the prevention of oral mucositis, specifically grade and days of oral mucositis in patients undergoing HCT compared to matched controls, as well as comparative days of hospitalization and infection rates. The session will further describe the expansion of the service to patients with solid tumors and leukemia/lymphoma. The session will also address treatment approaches specific to patients with sickle cell anemia undergoing gene therapy and the unique challenges with this patient population. Nurses are instrumental in introducing the benefits of PBM into the clinical practice environment. These benefits include reduction in mucositis grade, improvement in pain, and decreased days of hospitalization, as well as improved patient/family satisfaction. This study was supported by the APHON Research Grant.